SOADOR
ANIK icon

State of Alaska Department of Revenue’s Anika Therapeutics ANIK Stock Holding History

State of Alaska Department of Revenue’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,710
Closed -$252K – 1612
2023
Q2 		$252K Sell
9,710
-294
-3% -$7.87K ﹤0.01% 1574
2023
Q1 		$287K Sell
10,004
-169
-2% -$5.03K ﹤0.01% 1550
2022
Q4 		$301K Buy
10,173
+65
+0.6% +$1.85K ﹤0.01% 1541
2022
Q3 		$240K Sell
10,108
-76
-0.7% -$1.75K ﹤0.01% 1561
2022
Q2 		$227K Buy
10,184
+140
+1% +$3.12K ﹤0.01% 1578
2022
Q1 		$252K Sell
10,044
-180
-2% -$5.49K ﹤0.01% 1563
2021
Q4 		$366K Sell
10,224
-300
-3% -$12K ﹤0.01% 1548
2021
Q3 		$447K Buy
10,524
+570
+6% +$23.5K ﹤0.01% 1504
2021
Q2 		$430K Buy
9,954
+230
+2% +$9.8K ﹤0.01% 1496
2021
Q1 		$396K Sell
9,724
-1,340
-12% -$50.8K ﹤0.01% 1499
2020
Q4 		$500K Sell
11,064
-2,230
-17% -$84.6K 0.01% 1353
2020
Q3 		$470K Buy
13,294
+230
+2% +$8.31K 0.01% 1265
2020
Q2 		$492K Sell
13,064
-170
-1% -$5.6K 0.01% 1248
2020
Q1 		$382K Buy
13,234
+2,455
+23% +$99.3K 0.01% 1223
2019
Q4 		$558K Buy
10,779
+191
+2% +$11.1K 0.01% 1259
2019
Q3 		$581K Buy
10,588
+5,751
+119% +$295K 0.01% 1194
2019
Q2 		$196K Buy
4,837
+50
+1% +$1.82K ﹤0.01% 1459
2019
Q1 		$144K Buy
4,787
+35
+0.7% +$1.2K ﹤0.01% 1537
2018
Q4 		$159K Sell
4,752
-110
-2% -$3.97K ﹤0.01% 1481
2018
Q3 		$205K Buy
4,862
+40
+0.8% +$1.58K ﹤0.01% 1497
2018
Q2 		$154K Buy
4,822
+90
+2% +$3.71K ﹤0.01% 1539
2018
Q1 		$235K Buy
4,732
+1,830
+63% +$103K ﹤0.01% 1347
2017
Q4 		$156K Hold
2,902
– – ﹤0.01% 1389
2017
Q3 		$168K Buy
2,902
+30
+1% +$1.57K 0.01% 1064
2017
Q2 		$141K Buy
2,872
+1,272
+80% +$58.6K 0.01% 999
2017
Q1 		$69K Hold
1,600
– – 0.01% 1049
2016
Q4 		$78K Buy
+1,600
New +$74K 0.01% 730

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State of Alaska Department of Revenue's ANIK Position: Q3 2023 in Review

State of Alaska Department of Revenue sold out of Anika Therapeutics (ANIK) in Q3 2023, closing a stake of 9,710 shares — an estimated $252K sold.

State of Alaska Department of Revenue first reported a position in ANIK in Q4 2016 and held it in 27 quarters. The position peaked at $581K in Q3 2019. 116 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.

  • State of Alaska Department of Revenue reported no remaining Anika Therapeutics position as of Q3 2023 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 9,710 Anika Therapeutics shares in Q3 2023, an estimated $252K.
  • State of Alaska Department of Revenue first reported a position in Anika Therapeutics in Q4 2016 and held it in 27 quarters.
  • State of Alaska Department of Revenue's Anika Therapeutics position peaked at $581K in Q3 2019.
  • 116 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.

Based on State of Alaska Department of Revenue's 13F filing for Q3 2023, filed 16 Oct 2023.